Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) Director James Edward Doyle sold 1,402 shares of Exact Sciences stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $90.51, for a total transaction of $126,895.02. Following the completion of the transaction, the director now directly owns 54,110 shares of […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective lifted by Jefferies Financial Group from $82.00 to $100.00 in a report released on Wednesday morning, The Fly reports. Several other brokerages have also weighed in on EXAS. BTIG Research increased their target price on Exact Sciences from $80.00 to $90.00 in a research report […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price increased by Jefferies Financial Group from $82.00 to $100.00 in a report issued on Wednesday morning, The Fly reports. Other research analysts also recently issued research reports about the stock. Piper Sandler boosted their target price on shares of Exact Sciences from $70.00 to $80.00 […]
ExodusPoint Capital Management LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 17.8% during the fourth quarter, Holdings Channel reports. The firm owned 58,292 shares of the medical research company’s stock after selling 12,600 shares during the period. ExodusPoint Capital Management LP’s holdings in Exact Sciences were worth $2,886,000 […]
Thematics Asset Management bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 47,771 shares of the medical research company’s stock, valued at approximately $2,365,000. A number of other institutional investors have also […]